Abstract:Abstract Background Brain-derived neurotrophic factor (BDNF) is a known regulator of the development and maintenance of chronic pain in various chronic disorders. Together with its high-affinity tyrosine kinase type B (TrKB) receptor, BDNF is extensively expressed in the mammalian female reproductive system. However, BDNF and TrKB expression in different stages of endometriosis and the relationship between the expression of each in ectopic lesions and endometriosis pain remain unclear. Methods Sixty-two women who underwent laparoscopic surgery were enrolled in this study: forty-six diagnosed with ovarian endometrioma (study group) and sixteen diagnosed with ovarian benign tumours (control group). Samples from eutopic endometrium and ovarian endometriotic lesions were obtained at laparoscopic surgery. BDNF and TrKB messenger RNA (mRNA) and proteins levels in the eutopic and ectopic endometrium of both groups were measured by real-time PCR and immunohistochemical staining, respectively. Before the surgery the visual analogue scale (VAS) was used to measure dysmenorrhoea. Results BDNF and TrKB expression levels were higher in ovarian endometriotic lesions than in eutopic endometrium and normal endometrium ( P < 0.05), and there was no cyclical change. Furthermore, their expression levels were higher in eutopic endometrium than in normal endometrium ( P < 0.05), and BDNF and TrKB levels were higher in stage IV ovarian endometriotic lesions than in stage II and III lesions ( P < 0.05), with their expression being non-significantly higher in stage III than in stage II ( P > 0.05). Additionally, correlation coefficients for the association analysis between the mRNA expression of BDNF or TrKB in eutopic endometrium and the dysmenorrhoea VAS score were r = 0.52 and r = 0.56 for BDNF and TrKB, respectively ( P < 0.05). The correlation coefficients for the associations between BDNF and TrKB in both the eutopic and ectopic endometrium were r = 0.82 and r = 0.66, respectively ( P < 0.05). Conclusions BDNF and TrKB are closely related to dysmenorrhoea caused by endometriosis and may be important in the pathobiology or pathophysiology of endometriosis.

Expression of Human β Defensin-2 in Eutopic and Ectopic Endometrium of Women with Endometriosis

Expression of Human Β-Defensin-2 in the Eutopic and Ectopic Endometrial Tissues in Patients with Endometriosis.

Elevated Expressions of SHP2 and GAB2 Correlated with VEGF in Eutopic and Ectopic Endometrium of Women with Ovarian Endometriosis.

Decreased Expression of Pigment Epithelium-Derived Factor and Increased Microvascular Density in Ovarian Endometriotic Lesions in Women with Endometriosis.

Expression of aquaporins in eutopic and ectopic endometrium of patients with endometriosis

Expression of Vascular Cell Adhesion Molecule 1 and Intercellular Adhesion Molecule 1 in Endometrium and Serum in Endometriosis

Expression and Significance of TLR3 in Eutopic and Ectopic Endometrium from Women with Endometriosis

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Expression of Heparanase and Angiopoietin-2 in Patients with Endometriosis

Inhibitory Effect Of Recombinant Human Beta-Defensin-2 On Angiogenesis And Inflammatory Factors Of Rat Model Of Endometriosis

The expression of ER-α and ER-β in eutopic and ectopic endomerium epithelial cell of endometriosis.

Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

Expression and Significance of HGF,c-Met and MMP-2 in the Eutopic Endometrium of Endometriosis

BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea

Differentially expressed genes in human endometrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis.

Expression of Vascular Endothelial Growth Factor Receptor- Kinase Insertion Domain- Containing Receptor in Endometriosis and Human Normal Endometrium

Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in endometriosis

The Expression of Hypoxia Inducible Factor-1α in the Endometrium of Patients with Endometriosis

Differential Expression of EWI‐2 in Endometriosis, Its Functional Role and Underlying Molecular Mechanisms

Expression of Survivin and MMP-9 in Eutopic Endometrium of Patients with Endometriosis

Expression of Survivin and Bcl-2 in Endometriosis and Their Significance